Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Parkinson's disease | R-HSA-1643685 | 0 | thiostrepton | 16154490 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | thiostrepton | 16154490 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | thiostrepton | 16154490 | drug-path |
Melanogenesis | R-HSA-5662702 | map04916 | benzocaine | 2337 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | benzocaine | 2337 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | benzocaine | 2337 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | benzocaine | 2337 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | benzocaine | 2337 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | benzocaine | 2337 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | benzocaine | 2337 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | succinylsulfathiazole | 5315 | drug-path |
Jak-STAT signaling pathway | R-HSA-168638 | map04630 | succinylsulfathiazole | 5315 | drug-path |
Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | succinylsulfathiazole | 5315 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | succinylsulfathiazole | 5315 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | succinylsulfathiazole | 5315 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | succinylsulfathiazole | 5315 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | Prestwick-692 | None | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | Prestwick-692 | None | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | Prestwick-692 | None | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | Prestwick-692 | None | drug-path |